Outcome Switching in Triple Therapy in Influenza A(H3N2) Infection: An Open-label Randomized, Controlled, Phase IIb/III Trial

Affiliations

¹ Department of Medicine, McMaster University, Hamilton, ON, Canada. Electronic address: adam.mazzetti@medportal.ca.
² Department of Medicine, McMaster University, Hamilton, ON, Canada.

Comment

Adam Mazzetti et al. Chest. 2018 Oct.

. 2018 Oct;154(4):998-999.

doi: 10.1016/j.chest.2018.07.021.

¹ Department of Medicine, McMaster University, Hamilton, ON, Canada. Electronic address: adam.mazzetti@medportal.ca.
² Department of Medicine, McMaster University, Hamilton, ON, Canada.

No abstract available

Comment in

Response.
Hung IFN, Yuen KY. Hung IFN, et al. Chest. 2018 Oct;154(4):999. doi: 10.1016/j.chest.2018.07.022. Chest. 2018. PMID: 30290949 No abstract available.

Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination in the Treatment of Patients Hospitalized for Influenza A(H3N2) Infection: An Open-label Randomized, Controlled, Phase IIb/III Trial.
Hung IFN, To KKW, Chan JFW, Cheng VCC, Liu KSH, Tam A, Chan TC, Zhang AJ, Li P, Wong TL, Zhang R, Cheung MKS, Leung W, Lau JYN, Fok M, Chen H, Chan KH, Yuen KY. Hung IFN, et al. Chest. 2017 May;151(5):1069-1080. doi: 10.1016/j.chest.2016.11.012. Epub 2016 Nov 22. Chest. 2017. PMID: 27884765 Clinical Trial.